# Efficacy, Safety and Pharmacokinetic Study of Intravenous Clonidine Versus Midazolam for Sedation in Paediatric Patients

> **NCT02509273** · PHASE3 · TERMINATED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 28 (actual)

## Conditions studied

- Sedation in Intensive Care

## Interventions

- **DRUG:** Clonidine
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT02509273
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05
- **Primary completion:** 2018-10
- **Final completion:** 2018-10-22
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** lack of recruitment
- **Last updated:** 2019-01-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02509273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02509273, "Efficacy, Safety and Pharmacokinetic Study of Intravenous Clonidine Versus Midazolam for Sedation in Paediatric Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02509273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*